skip to main content

Weight Management in T2D — SCE Endocrinology MCQ

Instant feedback + full explanation. One question, done properly.

EasyEndocrinologyWeight Management in T2DSCE Endocrinology

A 60-year-old man with T2D, BMI 35 kg/m², and obstructive sleep apnoea asks whether weight loss improves diabetes and CV risk. What is recommended?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: BRecommend structured weight loss; consider GLP-1 RA and bariatric surgery if indicated

Weight reduction via lifestyle, anti-obesity pharmacotherapy (GLP-1 RA), and metabolic surgery in eligible patients improves glycaemia and CV risk. Insulin-induced weight gain is not a strategy; avoiding exercise is harmful; HCG is not recommended.

Reference: ADA Standards of Care (2025): Obesity and Weight Management for the Prevention and Treatment of T2D